Opportunities in the GLP-1 receptor agonist market include the development of new diabetes and obesity treatments with high efficacy, a growing product pipeline, and increasing R&D investments. Rising ...

Por JOHN WAWROWLos Bills de Buffalo acordaron adquirir al receptor abierto D.J. Moore de los Bears de Chicago el jueves, según dijeron a The Associated Press dos personas con conocimiento del ...

The researchers detected a specific delay of about 18 milliseconds between the waves in the visual cortex and the ...

In sum, the nonapeptide Oxytocin presents as a structurally well-defined peptide with a receptor system that is widely ...

Research suggests the drugs have potential for prevention and harm reduction in substance use disorders, writes Ziyad Al-Aly People taking glucagon-like peptide-1 (GLP-1) receptor agonists often ...

Understanding the Testosterone-Acne Connection If you thought acne breakouts were only a teenage problem, think again. Testosterone — the same hormone that fueled those adolescent flare-ups ...

Sustained GLP-1 receptor agonist therapy is linked to greater improvements in A1c levels than DPP-4 inhibitor therapy in patients with type 2 diabetes, a Danish real-world analysis shows.

What happens when a promising therapy falls short? Medscape spoke with Jeffrey Cummings, MD, who led the EVOKE trials of the GLP-1 semaglutide for AD, about what the results mean — and what comes next ...

As populations age worldwide, the decline of the immune system, a process known as immunosenescence, has become a critical ...

A recent research study found that a combination of the GLP-1 receptor agonist semaglutide and bimagrumab, an antibody that ...

GLP-1 medications may quiet the brain signals behind addiction, reducing substance use disorders and overdose risk across ...

Fc receptors function as the essential bridge between the innate and adaptive immune systems. When antibodies bind to their ...